VFEND ® (voriconazole) IV Injection, Tablets, Liquid. DESCRIPTION. VFEND ® (voriconazole), an azole antifungal agent is available as a lyophilized powder for solution for intravenous infusion, film-coated tablets for oral administration, and as a powder for oral suspension. Voriconazole tablets are indicated for use in patients 12 years of age and older in the treatment of the following fungal infections: Invasive Aspergillosis Film-coated tablet. Pink, capsule-shaped, film-coated tablet, of dimensions 20 mm x 10.4 mm, debossed with “123” on one side, plain on the other side. Valproate SODIUM (Depacon ®) The authors make no claims of the accuracy of the information contained herein; and these suggested doses and/or guidelines are not a substitute for clinical judgment. ABSTRACT. Polymorphism in solids is a common phenomenon in drugs, which can lead to compromised quality due to changes in their physicochemical properties, particularly solubility, and, therefore, reduce bioavailability. Detailed Carbamazepine dosage information for adults and children. Includes dosages for Bipolar Disorder, Epilepsy, Trigeminal Neuralgia and more; plus renal, liver and dialysis adjustments. Each film-coated tablet contains 90 mg ledipasvir and 400 mg sofosbuvir. Excipients with known effect: Each film-coated tablet contains 156.8 mg of lactose (as monohydrate) and 261 micrograms of sunset yellow FCF aluminium lake. We use cookies to make interactions with our website easy and meaningful, to better understand the use of our services, and to tailor advertising. Inactive ingredients contained in SUPRAX ® (cefixime) 400 mg tablets USP are: dibasic calcium phosphate, hypromellose, lactose monohydrate, magnesium stearate, microcrystalline cellulose, polyethylene glycol, pregelatinized starch, titanium dioxide, and triacetin. The key events in the development of the US generic drug industry after the Hatch-Waxman Act of 1984 are systematically reviewed, including the process of approval for generic drugs, bioequivalence issues including “switchability”, bioequivalence for complicated dosage forms, patent extension, generic drug safety, generic substitution and.